Simplex Trading, LLC Guardant Health, Inc. Transaction History

Simplex Trading, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.13 - $26.91 $732,410 - $1.15 Million	42,756 Added 169.73%	67,947 $1.4 Million
Q4 2023 Feb 02, 2024	BUY	$21.58 - $29.5 $220,504 - $301,431	10,218 Added 68.24%	25,191 $681,000
Q3 2023 Nov 01, 2023	BUY	$25.8 - $39.97 $386,303 - $598,470	14,973 New	14,973 $443,000
Q1 2023 Apr 27, 2023	SELL	$22.92 - $33.76 $7,380 - $10,870	-322 Reduced 44.6%	400 $9,000
Q4 2022 Feb 02, 2023	SELL	$25.44 - $59.78 $1.87 Million - $4.4 Million	-73,595 Reduced 99.03%	722 $19,000
Q3 2022 Nov 04, 2022	BUY	$43.66 - $61.0 $2.33 Million - $3.26 Million	53,451 Added 256.16%	74,317 $4 Million
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $65,507 - $175,816	2,273 Added 12.23%	20,866 $841,000
Q1 2022 May 02, 2022	BUY	$48.25 - $100.49 $775,474 - $1.62 Million	16,072 Added 637.52%	18,593 $1.23 Million
Q4 2021 Feb 23, 2022	BUY	$88.71 - $120.43 $223,637 - $303,604	2,521 New	2,521 $252,000
Q2 2021 Aug 12, 2021	SELL	$109.77 - $165.68 $1.38 Million - $2.09 Million	-12,601 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$127.04 - $179.1 $1.28 Million - $1.8 Million	10,048 Added 393.58%	12,601 $1.92 Million
Q4 2020 Feb 02, 2021	BUY	$99.96 - $135.93 $255,197 - $347,029	2,553 New	2,553 $329,000
Q1 2020 Apr 29, 2020	SELL	$59.04 - $88.81 $679,196 - $1.02 Million	-11,504 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$59.49 - $82.78 $684,372 - $952,301	11,504 New	11,504 $898,000
Q2 2019 Jul 26, 2019	SELL	$63.94 - $91.11 $118,672 - $169,100	-1,856 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$34.3 - $97.98 $63,660 - $181,850	1,856 New	1,856 $0

327

127M

843K

2.37M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.55B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.